Taipei, Taiwan
 

Guideline




Important Dates

Deadline of Abstract Submission: Tuesday, May 31, 2016 Thursday, June 30, 2016 (GMT+8 23:59:59)
Notification of Abstract Acceptance: Monday, August 1, 2016 (GMT+8 23:59:59)
Deadline of early-bird & presenter registration: Wednesday, August 31, 2016 (GMT+8 23:59:59)

Topics of Congress

A. Big Data Cloud and Laboratory Medicine

B. Age and Sex Related Testing

  • Aging Laboratory Medicine
  • Prenatal Screening
  • Pediatric Laboratory Medicine
  • Women Laboratory Medicine

C. Autoimmune Diseases

D. Infectious Diseases

  • Dengue Testing
  • Hepatitis Testing
  • HIV Testing
  • Influenza Testing
  • Tuberculosis Testing
  • Emergine Infectious Disease Testing

E. Laboratory Management

  • Integrated Diagnostics
  • Interpretative Comments In Laboratory Results
  • Laboratory Design
  • Laboratory Information System (LIS)
  • Patient Safety
  • Accreditation

F. Metabolic, Cardiac and Kidney Diseases

  • Cardiac and Kidney Biomarkers
  • Estimated Glomerular Filtration Rate (eGFR) Application
  • Vitamin D and Diseases

G. Molecular Diagnostic

  • Genetic Testing
  • Inherited Metabolic Disease
  • Cancer Genomic
  • GLP and QC in Molecular Diagnostics
  • Pharmacogenomics
  • Liquid Biopsy

H. Stem cell and Laboratory Medicine

I. Standardization and Harmonization

  • Traceability
  • Reference Intervals

J. Toxicology

K. Point of Care Testing

L. Mass Spectroscopy Application in Laboratory Medicine

Submission method

To submit the abstract in our on-line system is the ONLY way to complete the submission. Submission by letter, fax, e-mail or CD/DVD will NOT be accepted at any time. Please follow the steps and type the required information in the system to complete the submission.

Presentation type

The abstract could be presented by oral, poster or either one (no preference). The Organizing Committee reserves the rights to review and adjust the presentation type after the submission.

Accuracy of content:

Submitted abstracts may be edited online up to the abstract submission deadline. Abstracts CANNOT be edited or revised in any way after the deadline. All accepted abstracts will be published as submitted by the authors. Abstracts should be carefully written and edited prior to submission. The responsibility for the submission of an accurate and precise abstract lies solely with the authors.

Author Registration:

Abstracts without the presenter’s registration and payment will NOT be included in the final abstract book. However, the abstract could be uploaded first without any payment made. After the notification of acceptance, at least one author should finish the registration to ensure the presence for the submitted paper.

Submitting author / Presenting author:

If the submitting author is not also the presenting author, the submitting author is responsible for informing the presenting author of all communications received regarding the abstract. The presenting author must be registered by the deadline of presenters’ registration. If the presenting author does not complete the payment by the deadline of registration, the abstract will be REMOVED from the program.

Number of submissions:

There can only be ONE presenting author per abstract. The same abstract CANNOT be submitted multiple times by listing different presenting authors. If you are making multiple submissions, you only need to create one account. Use the same account (User name & Password) for any additional submissions. An unlimited number of abstracts can be submitted and presented by an individual.

Language:

The abstract must be written in ENGLISH.

Abstract Contents:

Title
Use the Title Case format and enter the title of the abstract in the column provided. The first letter of major words in the abstract title should be capitalized (e.g. “Big Data Cloud and Laboratory Medicine”). Use capital and lower case letters, as appropriate for abbreviations in the title. The responsibility for the accuracy of the abstract title lies solely with the submitting author.

Authors
Full name of all authors should be listed without degrees and titles, neither the initials.

Body

  • The body of the abstract is limited to 300 words, excluding the title and information on authors.
  • Only commonly accepted abbreviations should be used. Treatment groups or drug names should NOT be abbreviated. Less widely recognized abbreviations may be used if introduced on first usage.
  • Write numbers as numerals rather than words.
  • Only approved and generic (non-proprietary) drug names should be used.
  • Tables, charts, photographs and any other information are not acceptable as part of the abstract.
  • Do NOT enter the title, authors, or grant information into the abstract body submission field but include any references in the abstract body.

Encore abstract

The abstract that has been published in other seminars or journals etc. would not be accepted in the 2016 APFCB. It is highly encouraged to add new findings/results before your submission.

Abstract Publication

Submission of an abstract grants the Congress the rights to publish the abstract in both print and digital formats under the Congress (e.g. Congress Program Book, Official Website, Mobile APP etc.). There will be no further notification for the publication.

 

 
 

 

 

2016 APFCB Secretariat
Alice Tsao
Enjoy Professional Conference Organizer Corp.
Tel: +886-2-8226-1010 ext. 67
Fax: +886-2-8226-2785
E-Mail:
Congress: 2016apfcb@gmail.com
Exhibition: 2016apfcbexpo@gmail.com
Address: 6F-9, No.2, Jian 8th Rd., Zhonghe Dist., New Taipei City 235, Taiwan (R.O.C.)

Keep Me Update

Copyright © 2016 APFCB